Aortic Endograft Market

ID: MRFR/HC/34077-HCR

128 Pages

Rahul Gotadki

September 2025

Aortic Endograft Market Research Report By Product Type (Thoracic Aortic Endografts, Abdominal Aortic Endografts, Fenestrated Aortic Endografts, Branched Aortic Endografts), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Procedure Type (Elective, Emergency), By Material (Polymer, Metallic, Composite) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2034

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Aortic Endograft Market Summary

The Global Aortic Endograft Market is projected to grow from 3.75 USD Billion in 2024 to 6.84 USD Billion by 2034.

Key Market Trends & Highlights

Aortic Endograft Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 5.62 percent from 2025 to 2034.
By 2035, the market valuation is anticipated to reach 6.84 USD Billion, indicating robust growth potential.
In 2024, the market is valued at 3.75 USD Billion, reflecting a solid foundation for future expansion.
Growing adoption of minimally invasive procedures due to increasing patient preference is a major market driver.

Aortic Endograft Market

CAGR

5.62%

Market Size & Forecast

2024 Market Size	3.75 (USD Billion)
2035 Market Size	6.84 (USD Billion)
CAGR (2025-2035)	5.62%

Major Players

JOTECH, Terumo Corporation, B. Braun Melsungen, Abbott Laboratories, Teleflex, Boston Scientific, Asahi Intecc, Merit Medical Systems, Cook Medical, Medtronic, Gore Medical, AngioDynamics, Cardinal Health, Sientra, Endologix

Aortic Endograft Market Trends

The Global Aortic Endograft Market is currently shaped by several key drivers that foster its growth and development. Rising incidences of aortic aneurysms and vascular diseases fuel demand for minimally invasive surgical options. As healthcare providers seek effective ways to manage these conditions, advancements in technology and device efficacy create opportunities for better patient outcomes. Furthermore, an increased focus on improving patient recovery times drives the shift towards endovascular procedures, which are generally associated with lower complication rates.

This trend indicates a strong move towards adopting innovative solutions that enhance the quality of care.The market also presents numerous opportunities for exploration and capture, particularly in emerging regions where healthcare infrastructure is expanding. Increased awareness and emphasis on preventive healthcare can create a demand for screening and early intervention. Collaborations and partnerships between device manufacturers and healthcare institutions can accelerate research and development, leading to the introduction of new and more effective endograft solutions. The rise of personalized medicine offers a path for creating tailored endograft therapies that accommodate individual patient needs, ultimately expanding market potential.

Recent trends highlight a significant shift towards hybrid surgical techniques and the incorporation of advanced imaging technologies.Many healthcare providers are leveraging robotic-assisted surgeries to enhance precision in endograft placement. Additionally, the development of bioresorbable materials and designs that promote more natural healing processes reflects ongoing innovation in the market. Regulatory approvals for novel devices are also becoming more streamlined, facilitating quicker access to patients needing these critical interventions. The growing importance of patient-centered care continues to emphasize the need for effective, safe, and patient-friendly surgical options within the aortic endograft landscape.

The ongoing advancements in minimally invasive surgical techniques are likely to enhance the adoption of aortic endografts, thereby transforming the landscape of vascular interventions.

U.S. National Institutes of Health

Aortic Endograft Market Drivers

Rising Prevalence of Aortic Aneurysms

The increasing incidence of aortic aneurysms globally is a primary driver for the Global Aortic Endograft Market Industry. As populations age, the risk factors associated with aortic aneurysms, such as hypertension and atherosclerosis, become more prevalent. In 2024, the market is projected to reach 3.75 USD Billion, reflecting the urgent need for effective treatment options. The growing awareness among healthcare professionals and patients regarding the benefits of endovascular procedures further fuels market growth. This trend is expected to continue, with the market anticipated to expand significantly as the global population ages and the prevalence of cardiovascular diseases rises.

Market Segment Insights

Aortic Endograft Market Product Type Insights

The Global Aortic Endograft Market is experiencing steady growth driven by increasing awareness and the rising prevalence of aortic diseases. Within the broad Product Type segment, the market is categorized into Thoracic Aortic Endografts, Abdominal Aortic Endografts, Fenestrated Aortic Endografts, and Branched Aortic Endografts. In 2023, Thoracic Aortic Endografts were valued at 1.2 USD Billion, highlighting their significant role in treating thoracic aortic aneurysms. This segment shows strong growth potential, projected to reach 2.0 USD Billion in 2032. The importance of Thoracic Aortic Endografts is evident; they are crucial for emergency situations where immediate interventions are necessary.

The Abdominal Aortic Endografts segment, with a valuation of 1.6 USD Billion in 2023, dominates this market due to the higher prevalence of abdominal aortic aneurysms globally.

This segment is expected to grow consistently, achieving a valuation of 2.6 USD Billion by 2032. The rising geriatric population and an increase in lifestyle-related diseases contribute significantly to the demand for this type of endograft treatment, illustrating its crucial importance in the Global Aortic Endograft Market. Fenestrated Aortic Endografts, valued at 0.8 USD Billion in 2023, offer a tailored solution to complex aortic anatomy, facilitating the treatment for patients with branched vessels. This segment is projected to witness growth, reaching an estimated 1.3 USD Billion by 2032.

The unique design of fenestrated endografts makes them significant for specialized procedures, catering to a niche but vital area in aortic repair operations.

Branched Aortic Endografts, while valued lower at 0.32 USD Billion in 2023 and expected to rise to 0.61 USD Billion by 2032, play an essential role in aortic repair for patients with challenging anatomical configurations. The market growth for this segment indicates a growing recognition of the need for advanced surgical solutions.

Aortic Endograft Market End User Insights

In 2023, the Global Aortic Endograft Market is expected to witness significant engagement from various End User categories, primarily encompassing hospitals, ambulatory surgical centers, and specialty clinics. Among these, hospitals hold a major share due to their comprehensive facilities and resources for handling complex procedures, making them a pivotal setting for aortic endograft deployments.

Ambulatory surgical centers are on the rise as they offer a convenient and cost-effective alternative for less complicated surgeries, catering to a growing patient demand for outpatient procedures.Specialty clinics often focus on vascular health, thus playing a critical role in providing tailored care and advanced treatment options specifically for aortic conditions. The increase in cardiovascular diseases, coupled with the aging population, has paved the way for enhanced market growth. However, challenges such as high operational costs and regulatory constraints pose hurdles for these facilities.

Nevertheless, the ongoing advancements in medical technologies and procedures present lucrative opportunities for innovation in the Global Aortic Endograft Market revenue generation and overall advancement in the industry.As the market data evolves, understanding these dynamics will be crucial for stakeholders.

Aortic Endograft Market Procedure Type Insights

The Global Aortic Endograft Market showcases distinct segmentation by Procedure Type, primarily categorized into Elective and Emergency procedures, reflecting the varied treatment requirements for aortic diseases. As of 2023, the overall market is valued at 3.36 billion USD, underscoring the increasing demand for innovative medical solutions in this field. Elective procedures are critical, often allowing for planned interventions that enhance patient outcomes and reduce surgical risks. They typically involve careful patient selection and timing, leading to smoother surgeries.Conversely, Emergency procedures address critical and urgent situations, often involving life-threatening conditions, making them highly significant in the aortic care spectrum.

The importance of this segment is evident as it caters to unexpected medical crises, necessitating rapid interventions and highlights the urgency for effective endograft solutions. Overall, the Global Aortic Endograft Market revenue is expected to witness robust growth driven by advancements in technology and increasing awareness of aortic diseases, creating opportunities for improved treatment methodologies and patient care.Market growth is supported by the demand for effective management solutions that cater to both planned and unplanned medical scenarios within this essential healthcare domain.

Aortic Endograft Market Material Insights

The Global Aortic Endograft Market, valued at 3.36 billion USD in 2023, showcases a diverse segmentation in its Material component, which plays a vital role in the functionality and efficacy of aortic endografts. The demand for advanced materials, specifically Polymer, Metallic, and Composite, is rising as healthcare professionals seek improved solutions for aortic interventions. Polymers, known for their flexibility and biocompatibility, are increasingly preferred due to their adaptability in various medical settings.

Metallic materials offer strength and durability, making them significant for high-pressure applications in aortic repairs.Composite materials combine the advantages of both polymers and metals, fostering innovative approaches that enhance the structural integrity of endografts. The trends within the Global Aortic Endograft Market indicate a shift towards materials that improve patient outcomes and longevity of devices. Factors such as an aging population, increasing prevalence of cardiovascular diseases, and advancements in material science are driving market growth.

Challenges remain, including the need for long-term data on the performance of newer material technologies, yet the opportunities for market expansion remain robust, driven by healthcare innovations and rising demand for less invasive surgical options.

Get more detailed insights about Aortic Endograft Market Research Report - Forecast Till 2034

Request Free Sample

Regional Insights

The Global Aortic Endograft Market revenue showcases substantial growth across various regions. In 2023, North America dominates the market with a valuation of 1.56 USD Billion, and this segment is expected to grow to 2.51 USD Billion by 2032, reflecting its majority holding in the industry. Europe follows closely as the second-largest market, valued at 1.02 USD Billion in 2023, with an anticipated rise to 1.69 USD Billion in 2032, underscoring its significant role in this sector.

The Asia-Pacific region holds a vital position, initially valued at 0.6 USD Billion in 2023, projecting growth to 1.0 USD Billion by 2032, reflecting an increasing demand for advanced healthcare solutions.South America and the Middle East Africa (MEA) contribute smaller shares, valued at 0.1 USD Billion and 0.08 USD Billion in 2023, respectively, with modest growth expected in the coming years, reaching 0.15 USD Billion by 2032. The growth in these regions is bolstered by the increasing prevalence of cardiovascular diseases and the rising adoption of minimally invasive surgeries, thus creating substantial opportunities for market expansion.

Aortic Endograft Market Regional Insights

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Global Aortic Endograft Market is witnessing significant growth driven by advancements in medical technology and an increasing prevalence of aortic aneurysms globally. As the market evolves, key players are focusing on innovation, product development, and strategic collaborations to enhance their competitive positioning. The landscape is characterized by a blend of established firms and emerging players, all vying for market share by offering various product lines tailored to meet the specific needs of healthcare providers and patients.

The competitive environment is intensively shaped by regulatory challenges, reimbursement frameworks, and growing awareness of endovascular procedures, which are less invasive than traditional surgical interventions. In this dynamic market, differentiation through technology, effectiveness, and patient outcomes is increasingly pivotal for companies aiming to secure their foothold.JOTECH has carved out a notable presence in the Global Aortic Endograft Market through its commitment to quality and innovation.

The company focuses on developing advanced endovascular solutions that prioritize patient safety and optimal clinical outcomes. Its strengths lie in robust research capabilities and a strong pipeline of products designed to address varying anatomical challenges presented by aortic diseases. JOTECH's emphasis on quality control and testing ensure that its endografts not only meet but often exceed regulatory standards, enhancing its reputation among clinicians and hospitals alike.

Furthermore, JOTECH fosters collaboration with healthcare professionals to gain insights that inform product development, ultimately translating into a competitive edge in the market.Terumo Corporation plays a significant role in the Global Aortic Endograft Market, bringing to the table a wealth of expertise in medical devices and a commitment to innovation.

The company's focus on research and development facilitates the creation of cutting-edge endograft solutions that align with current clinical needs and technological advancements. Terumo Corporation's global footprint and established distribution networks enable it to ensure the widespread availability of its products, fostering trust and reliance among healthcare providers. Its strength is accentuated by strategic partnerships that enhance its market reach, along with a strong emphasis on educational initiatives that empower clinicians with the knowledge needed to utilize its products effectively. The combination of these elements positions Terumo Corporation as a formidable competitor in the continuously evolving landscape of aortic endografts.

Key Companies in the Aortic Endograft Market market include

Industry Developments

Q2 2024: FDA Approves Medtronic's Valiant Navion Thoracic Stent Graft System for Expanded Indications The FDA granted expanded approval for Medtronic's Valiant Navion Thoracic Stent Graft System, allowing its use in a broader range of thoracic aortic aneurysm and dissection cases. This regulatory milestone enables Medtronic to address more complex aortic pathologies with its endograft technology.
Q2 2024: Terumo Receives CE Mark for RelayPro Thoracic Stent-Graft System Terumo announced it has received CE Mark approval for its RelayPro Thoracic Stent-Graft System, enabling commercialization in the European Union. The device is designed for minimally invasive repair of thoracic aortic aneurysms.
Q2 2024: Endologix Announces FDA Approval of ALTO Abdominal Stent Graft System Endologix received FDA approval for its ALTO Abdominal Stent Graft System, a next-generation device for endovascular aneurysm repair (EVAR). The approval allows Endologix to market the device in the United States.
Q3 2024: Boston Scientific Completes Acquisition of Veniti, Expanding Vascular Portfolio Boston Scientific completed its acquisition of Veniti, a company specializing in venous stent technology, to strengthen its vascular intervention portfolio, including aortic endograft solutions.
Q3 2024: Cook Medical Launches Zenith Fenestrated AAA Endovascular Graft in Japan Cook Medical announced the commercial launch of its Zenith Fenestrated AAA Endovascular Graft in Japan following regulatory approval, expanding its global reach in the aortic endograft market.
Q4 2024: Terumo Opens New Manufacturing Facility for Aortic Endografts in Ireland Terumo inaugurated a new manufacturing facility in Ireland dedicated to the production of aortic endografts, aiming to meet growing global demand and enhance supply chain resilience.
Q4 2024: Gore Receives FDA Approval for Conformable Excluder AAA Endoprosthesis Gore announced FDA approval for its Conformable Excluder AAA Endoprosthesis, a device designed to treat abdominal aortic aneurysms with improved anatomical conformability.
Q1 2025: Medtronic Launches Valiant Navion Thoracic Stent Graft System in China Medtronic launched its Valiant Navion Thoracic Stent Graft System in China after receiving regulatory clearance, expanding its presence in the Asia-Pacific aortic endograft market.
Q1 2025: Endologix Announces Strategic Partnership with Japanese Distributor for ALTO Device Endologix entered a strategic partnership with a leading Japanese medical device distributor to commercialize its ALTO Abdominal Stent Graft System in Japan.
Q2 2025: Boston Scientific Receives FDA Approval for New Aortic Stent Graft System Boston Scientific received FDA approval for its latest aortic stent graft system, enabling the company to offer a new solution for endovascular aortic repair in the United States.
Q2 2025: Gore Launches Next-Generation TAG Thoracic Endoprosthesis in Europe Gore announced the European launch of its next-generation TAG Thoracic Endoprosthesis, designed for minimally invasive treatment of thoracic aortic aneurysms.
Q2 2025: Terumo Announces Partnership with European Hospital Network for RelayPro Device Terumo entered a partnership with a major European hospital network to provide its RelayPro Thoracic Stent-Graft System for clinical use in thoracic aortic aneurysm repair.

Future Outlook

Aortic Endograft Market Future Outlook

The Aortic Endograft Market is projected to grow at a 5.62% CAGR from 2024 to 2034, driven by technological advancements, increasing prevalence of aortic diseases, and rising healthcare expenditure.

New opportunities lie in:

Develop innovative, patient-specific endografts utilizing 3D printing technology.
Expand telemedicine services for remote monitoring of aortic patients.
Invest in partnerships with healthcare providers for integrated care solutions.

By 2035, the Aortic Endograft Market is expected to achieve substantial growth, reflecting advancements in treatment options and patient care.

Market Segmentation

Aortic Endograft Market End User Outlook

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Aortic Endograft Market Material Outlook

Polymer
Metallic
Composite

Aortic Endograft Market Regional Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Aortic Endograft Market Product Type Outlook

Thoracic Aortic Endografts
Abdominal Aortic Endografts
Fenestrated Aortic Endografts
Branched Aortic Endografts

Aortic Endograft Market Procedure Type Outlook

Elective
Emergency

Report Scope

Report Attribute/Metric	Details
Market Size 2024	3.75 (USD Billion)
Market Size 2025	3.96 (USD Billion)
Market Size 2034	6.48 (USD Billion)
Compound Annual Growth Rate (CAGR)	5.63 % (2025 - 2034)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2034
Historical Data	2020 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	JOTECH, Terumo Corporation, B. Braun Melsungen, Abbott Laboratories, Teleflex, Boston Scientific, Asahi Intecc, Merit Medical Systems, Cook Medical, Medtronic, Gore Medical, AngioDynamics, Cardinal Health, Sientra, Endologix
Segments Covered	Product Type, End User, Procedure Type, Material, Regional
Key Market Opportunities	Rising prevalence of aortic diseases, Technological advancements in endograft design, Increasing geriatric population globally, Expanding health insurance coverage, Growing demand for minimally invasive procedures
Key Market Dynamics	rising prevalence of aortic diseases, technological advancements in endografts, increasing geriatric population, favorable reimbursement policies, growing demand for minimally invasive procedures
Countries Covered	North America, Europe, APAC, South America, MEA

FAQs

What is the expected market size of the Global Aortic Endograft Market in 2034?

The Global Aortic Endograft Market is expected to be valued at 6.48 USD Billion in 2034.

What is the compound annual growth rate (CAGR) for the Global Aortic Endograft Market from 2025 to 2034?

The expected CAGR for the Global Aortic Endograft Market from 2025 to 2034 is 5.63%.

Which region is projected to have the largest market share in the Global Aortic Endograft Market by 2032?

North America is projected to have the largest market share, valued at 2.51 USD Billion by 2032.

What will be the market size of Thoracic Aortic Endografts in 2032?

The market size for Thoracic Aortic Endografts is expected to reach 2.0 USD Billion by 2032.

How much is the Abdominal Aortic Endografts market valued at in 2023?

The Abdominal Aortic Endografts market is valued at 1.6 USD Billion in 2023.

What is the anticipated market size for Fenestrated Aortic Endografts in 2032?

Fenestrated Aortic Endografts are expected to have a market size of 1.3 USD Billion in 2032.

What is the projected market size for Branched Aortic Endografts in 2025 ?

Branched Aortic Endografts are anticipated to be valued at approximately 0.32 USD Billion in 2023.

Who are the key players in the Global Aortic Endograft Market?

Key players include Medtronic, Abbott Laboratories, Boston Scientific, and Gore Medical, among others.

What is the expected market size for the APAC region in the Global Aortic Endograft Market by 2032?

The APAC region is expected to reach a market size of 1.0 USD Billion by 2032.

What are the growth drivers for the Global Aortic Endograft Market?

Key growth drivers include advancements in medical technology and the increasing prevalence of aortic diseases.

Aortic Endograft Market Research Report - Forecast Till 2034 Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027